Tumor -Associated MUC1 Regulates TGF-β Signaling and Function in Pancreatic Ductal Adenocarcinoma
Priyanka Grover(University of North Carolina at Charlotte), Pinku Mukherjee(University of North Carolina at Charlotte), Nitika Nitika(University of North Carolina at Charlotte), Andrew W. Truman(University of North Carolina at Charlotte), Mohammad Ahmad(University of North Carolina at Charlotte), Mukulika Bose(University of North Carolina at Charlotte), Cory Brouwer(University of North Carolina at Charlotte), Mahboubeh Yazdanifar(Stanford University), Shu-ta Wu(University of North Carolina at Charlotte), Sritama Nath(University of North Carolina at Charlotte), Ru Zhou(University of British Columbia), Alexa Sanders(University of North Carolina at Charlotte)
Cited by 1
Related Papers
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
|Pharmacology & Therapeutics|2016|921
MUC1: a multifaceted oncoprotein with a key role in cancer progression
|Trends in Molecular Medicine|2014|854
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
|Oncogene|2010|269
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
|Oncogenesis|2013|176
Discovery of 1-{(3<i>R</i>,4<i>R</i>)-3-[({5-Chloro-2-[(1-methyl-1<i>H</i>-pyrazol-4-yl)amino]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
|Journal of Medicinal Chemistry|2016|93